Search
for
Sort by
Research 601–630 of 1000+
- Global research trends and hotspots in the application of platelet‐rich plasma to hair growth from 2006 to 2023: Bibliometric and visual analysis
- JOLT: A Noninvasive Solution for the Correction of the Jowl
- Evaluation of the Awareness, Beliefs, and Psychological Impact of Patients with Alopecia Areata in Makkah City, Saudi Arabia
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- Patient Satisfaction and Quality of Life Among Adult Women with Androgenetic Alopecia Using 5% Topical Minoxidil.
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Assessment of college students’ mental health status based on temporal perception and hybrid clustering algorithm under the impact of public health events
- Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990–2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021
- Ex Vivo Assessment of Heat and Humidity Effects on Human Skin and Potential Protection by Kombucha Tea Extract
- 465 Multicenter prospective study on the efficacy of narrowband ultraviolet B treatment and its effect on quality of life, anxiety, depression in plaque psoriasis patients
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS—A GERMAN SURVEY
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Dermatology patient-derived health utility of facial angiofibroma associated with tuberous sclerosis complex
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- Body Representation in Patients with Severe Spinal Cord Injury: A Pilot Study on the Promising Role of Powered Exoskeleton for Gait Training
- Hair Breakage in Patients of African Descent: Role of Dermoscopy
- Histopathological investigation of clinically non‐affected perilesional scalp in alopecias detected unexpected spread of disease activities
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Laser-assisted Hair Regrowth
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Alterations in Corneal Sensitivity, Staining and Biomechanics of Alopecia Areata Patients: Novel Findings in a Case-Control Study
- Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
- Global trends in platelet-rich plasma research: A bibliometric review with hotspot visualization
- The Evolving Global Burden of Alopecia Areata in Young Adults: High-Income Nations Bear the Greatest Impact